A phase II study of palbociclib (P) for previously treated cell cycle gene alteration positive patients (pts) with stage IV squamous cell lung cancer (SCC): Lung-MAP sub -study SWOG S1400C.

被引：8

作者：

Edelman, Martin J.

Redman, Mary Weber

Albain, Kathy S.

McGary, Eric C.

Rafique, Norman

Petro, Daniel P.

Waqar, Saiama Naheed

Miao, Jieling

Griffin, Katie

Papadimitrakopoulou, Vassiliki

Kelly, Karen

Gandara, David R.

Herbst, Roy S.

机构：

[1] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

[3] Loyola Univ, Chicago Stritch Sch Med, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA

[4] Kaiser Permanente, Cadillac, CA USA

[5] Tricty Hematol Oncol Associates, Mercy Med Ctr, Massilon, OH USA

[6] Univ Pittsburgh, Canc Inst, Pittsburgh, PA USA

[7] Washington Univ, Div Oncol, Dept Med, Sch Med, St Louis, MO USA

[8] Fred Hutchinson Canc Res Ctr, SWOG Stat Ctr, 1124 Columbia St, Seattle, WA 98104 USA

[9] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[10] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA 95817 USA

[11] Univ Calif Davis, Sacramento, CA 95817 USA

[12] Yale Sch Med, New Haven, CT USA

来源：

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.9056

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9056

引用

页数：5